A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy

Pomeroy, E. J., Hunzeker, J. T., Kluesner, M. G., Lahr, W. S., Smeester, B. A., Crosby, M. R., Lonetree, C., Yamamoto, K., Bendzick, L., Miller, J. S., Geller, M. A., Walcheck, B., Felices, M., Webber, B. R., Starr, T. K., Moriarity, B. S.  A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy.  Molecular Therapy. 2020; 28(1), 52-63.  doi:10.1016/j.ymthe.2019.10.009

Privacy Preference Center

Necessary

Advertising

Analytics

Other